In a previous work on a mice model of mesothelioma, we have shown that the use of these drugs alone did not have a strong anti-tumoral effect, while the use of the combination of decitabine/HDAC inhibitors, VPA or SAHA, was efficient [12]. The gene discussed is HDAC9; the disease is mesothelioma.